Jeil Pharma
₩7,500
0
-₩140-1.83% Wednesday 06:30
Statistics
Day High
7,660
Day Low
7,360
52W High
9,850
52W Low
6,050
Volume
992
Avg. Volume
7,738
Mkt Cap
115.13B
P/E Ratio
-
Dividend Yield
0.93%
Dividend
70
Upcoming
Dividends
0.93%Dividend Yield
Apr 26
₩70
Apr 25
₩50
Apr 24
₩50
Apr 23
₩50
Apr 22
₩65
10Y Growth
1.55%
5Y Growth
N/A
3Y Growth
11.87%
1Y Growth
40%
Earnings
10MayExpected
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2023
Q1 2024
-145
-52
40
132
Expected EPS
N/A
Actual EPS
N/A
Financials
0.74%Profit Margin
Profitable150.4BRevenue
1.11BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Jeil Pharma Holdings Inc. is a South Korean pharmaceutical enterprise focused on the production and sale of active pharmaceutical ingredients (APIs), incrementally modified drugs (IMDs), and generic pharmaceuticals. The company's comprehensive API portfolio encompasses a variety of therapeutic areas, including antimicrobials, gastrointestinal remedies, cardiovascular medications, neuropsychiatric treatments, oncology drugs, endocrinology products, urology solutions, antivirals, and antihistamines, in addition to transdermal patch formulations. Furthermore, Jeil Pharma Holdings offers a broad selection of finished dosage forms addressing conditions such as bacterial, fungal, and viral infections; cardiovascular and endocrine disorders; neurological and gastrointestinal ailments; urological and oncological diseases. Its extensive range also features antihistamines, rheumatology, respiratory, otolaryngological, hepatic, and purgative agents. With a global presence, Jeil Pharma Holdings Inc. exports its products to approximately 40 countries, spanning regions like Southeast Asia, Central and South America, and Africa. Founded in 1959, the company's headquarters are situated in Seoul, South Korea.
Show more...
CEO
Seung-Soo Han
Employees
40
Country
South Korea
ISIN
KR7002620003
Listings
0 Comments
Share your thoughts
FAQ
What is Jeil Pharma stock price today?▼
The current price of 002620.KQ is ₩7,500 KRW — it has decreased by -1.83% in the past 24 hours. Watch Jeil Pharma stock price performance more closely on the chart.
What is Jeil Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Jeil Pharma stocks are traded under the ticker 002620.KQ.
Is Jeil Pharma stock price growing?▼
002620.KQ stock has fallen by -2.85% compared to the previous week, the month change is a +1.21% rise, over the last year Jeil Pharma has showed a -13.69% decrease.
What is Jeil Pharma market cap?▼
Today Jeil Pharma has the market capitalization of 115.13B
What is Jeil Pharma revenue for the last year?▼
Jeil Pharma revenue for the last year amounts to 150.4B KRW.
What is Jeil Pharma net income for the last year?▼
002620.KQ net income for the last year is 1.11B KRW.
Does Jeil Pharma pay dividends?▼
Yes, 002620.KQ dividends are paid annual. The last dividend per share was 70 . As of today, Dividend Yield (FWD)% is 0.93%.
How many employees does Jeil Pharma have?▼
As of September 27, 2026, the company has 40 employees.
In which sector is Jeil Pharma located?▼
Jeil Pharma operates in the Health & Wellness sector.
When did Jeil Pharma complete a stock split?▼
The last stock split for Jeil Pharma was on April 17, 2006 with a ratio of 10:1.
Where is Jeil Pharma headquartered?▼
Jeil Pharma is headquartered in Seoul, South Korea.